These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 28467775)
1. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study. Xu Y; Zheng X; Bai X; Li P; Ma H; Wang J; Hu X; Chen M Oncotarget; 2017 Jul; 8(30):49084-49092. PubMed ID: 28467775 [TBL] [Abstract][Full Text] [Related]
2. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study. Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118 [TBL] [Abstract][Full Text] [Related]
3. Outcome and toxicity of intensity modulated radiotherapy with simultaneous integrated boost in locally advanced non-small cell lung cancer patients. Fondevilla Soler A; López-Guerra JL; Dzugashvili M; Sempere Rincón P; Sautbaet A; Castañeda P; Díaz JM; Praena-Fernandez JM; Rivin Del Campo E; Azinovic I Clin Transl Oncol; 2017 Dec; 19(12):1469-1477. PubMed ID: 28589434 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study. Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169 [TBL] [Abstract][Full Text] [Related]
5. Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation. Swanick CW; Lin SH; Sutton J; Naik NS; Allen PK; Levy LB; Liao Z; Welsh JW; Komaki R; Chang JY; Gomez DR Clin Lung Cancer; 2015 Mar; 16(2):156-63. PubMed ID: 25467928 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study. Ji K; Zhao LJ; Liu WS; Liu ZY; Yuan ZY; Pang QS; Wang J; Wang P Br J Radiol; 2014 Mar; 87(1035):20130562. PubMed ID: 24588668 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial. Wang L; Liu L; Cao Y; Chen X; Liu S; Li X; Han J; Wang Q; Han C BMC Cancer; 2024 Jun; 24(1):679. PubMed ID: 38831450 [TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735 [TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience. Xu Y; Wang Z; Liu G; Zheng X; Wang Y; Feng W; Lai X; Zhou X; Li P; Ma H; Wang J; Hu X; Chen M J Cancer Res Ther; 2016 Oct; 12(Supplement):82-88. PubMed ID: 27721262 [TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience. Mantel F; Müller E; Kleine P; Zimmermann M; Exner F; Richter A; Weick S; Ströhle S; Polat B; Höcht S; Flentje M Strahlenther Onkol; 2021 May; 197(5):405-415. PubMed ID: 33725133 [TBL] [Abstract][Full Text] [Related]
11. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer]. You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970 [TBL] [Abstract][Full Text] [Related]
12. An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy. Ma L; Qiu B; Li Q; Chen L; Wang B; Hu Y; Liu M; Zhang L; Huang Y; Deng X; Xia Y; Lin M; Liu H Radiat Oncol; 2018 Jul; 13(1):130. PubMed ID: 30016978 [TBL] [Abstract][Full Text] [Related]
13. [Application of Simultaneous Integrated Boost Intensity Modulated Radiotherapy in Locally Advanced Non-small Cell Lung Cancer]. You J; Yang D; Li D; Jiang L; Yu R; Yu H; Xu B; Wang W; Shi A Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):696-701. PubMed ID: 31771738 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer. Ling DC; Hess CB; Chen AM; Daly ME Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127 [TBL] [Abstract][Full Text] [Related]
15. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer. Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946 [TBL] [Abstract][Full Text] [Related]
16. Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin. Uyterlinde W; Belderbos J; Baas C; van Werkhoven E; Knegjens J; Baas P; Smit A; Rikers C; van den Heuvel M Clin Lung Cancer; 2013 Sep; 14(5):541-8. PubMed ID: 23835165 [TBL] [Abstract][Full Text] [Related]
17. Prospective study of special stage II (T2b-3N0M0) non-small-cell lung cancer treated with hypofractionated-simultaneous integrated boost-intensity modulated radiation therapy. Zhang W; Liu C; Lin H; Song Y; Huang W; Li H; Li M; Li B J Cancer Res Ther; 2015; 11(2):381-7. PubMed ID: 26148604 [TBL] [Abstract][Full Text] [Related]
18. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064 [TBL] [Abstract][Full Text] [Related]
19. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy. Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491 [TBL] [Abstract][Full Text] [Related]
20. Optimized radiotherapy to improve clinical outcomes for locally advanced lung cancer. Jaksic N; Chajon E; Bellec J; Corre R; Ricordel C; de Latour B; Lena H; Schick U; de Crevoisier R; Castelli J Radiat Oncol; 2018 Aug; 13(1):147. PubMed ID: 30103774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]